Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Takeda Pharmaceutical Q2 Adj. EPS $0.43 Misses $0.44 Estimate, Sales $7.520B Miss $8.080B Estimate

Author: Benzinga Newsdesk | October 30, 2025 02:17am
Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.44 by 2.27 percent. This is a 4.44 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $7.520 billion which missed the analyst consensus estimate of $8.080 billion by 6.93 percent. This is a 4.82 percent decrease over sales of $7.901 billion the same period last year.

Posted In: TAK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist